Drug Profile
SAI-TGF-alpha
Alternative Names: Cancer vaccine TGF-alpha - Micromet; TGF-alpha cancer vaccine - MicrometLatest Information Update: 09 Mar 2012
Price :
$50
*
At a glance
- Originator Center of Molecular Immunology
- Developer Amgen; Center of Molecular Immunology
- Class Cancer vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Cancer
Most Recent Events
- 07 Mar 2012 Micromet Inc has been acquired by Amgen
- 02 Mar 2012 No development reported - Preclinical for Cancer in North America (unspecified route)
- 13 Aug 2009 SAI-TGF-alpha is available for licensing or purchase (http://www.micromet.de)